Table 2.
| Participant | Phase I | Phase II | ||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Target | Condition | % increase |
d2 | Target | Condition | % increase |
d2 | |
| A | /ɹV/ | PML+US | 74.9 | 20.59 | /Vɹ/ | PML+NoUS | 47.0 | 3.71 |
| B | /Vɹ/ | PML+US | 39.4 | 4.01 | /ɝ/ | PML+NoUS | 15.0 | 4.24 |
| C | /Vɹ/ | PML+US | 25.6 | 1.38 | /Cɹ/ | PML+NoUS | −4.4 | −0.43 |
| D | /ɹV/ | PML+US | 21.9 | 4.79 | /Vɹ/ | PML+NoUS | 19.7 | 6.45 |
| E | /ɹV/ | PML+US | 18.3 | 1.32 | /Vɹ/ | PML+NoUS | 52.9 | 5.51 |
| F | /Vɹ/ | PML+US | 6.7 | 0.74 | /ɹV/ | PML+NoUS | 87.5 | 27.24 |
|
| ||||||||
| Mean (SD) | Phase I US | 31.1 (23.9) |
4.92 (7.76) |
Phase II NoUS | 36.3 (32.9) |
7.79 (9.82) |
||
|
| ||||||||
| G | /ɹV/ | PML+NoUS | 72.4 | 12.34 | /Vɹ/ | PML+US | 17.1 | 1.34 |
| H | /ɹV/ | PML+NoUS | 58.4 | 10.09 | /Vɹ/ | PML+US | 59.1 | 11.19 |
| I | /Vɹ/ | PML+NoUS | 39.2 | 3.04 | /ɹV/ | PML+US | 24.3 | 2.44 |
| J | /Vɹ/ | PML+NoUS | 6.8 | 1.15 | /ɝ/ | PML+US | 69.7 | 14.56 |
| K | /Cɹ/ | PML+NoUS | 4.2 | 0.53 | /Vɹ/ | PML+US | −0.9 | −0.43 |
| L | /Vɹ/ | PML+NoUS | 0 | 0 | /ɹV/ | PML+US | 0.3 | 0.15 |
|
| ||||||||
| Mean (SD) | Phase I PML+NoUS | 30.2 (31.0) |
4.52 (5.33) |
Phase II PML+US | 28.25 (29.79) |
4.88 (6.37) |
||
|
| ||||||||
| Mean (SD) | Phase I Total | 30.7 (26.4) |
4.72 (6.35) |
Phase II Total | 32.3 (30.2) |
6.33 (8.03) |
||
|
| ||||||||
| Mean (SD) | PML+US Total | 29.7 (25.8) |
4.90 (6.77) |
PML+NoUS Total | 33.2 (30.6) |
6.16 (7.72) |
||
Note: PML=Principles of Motor Learning, US=Ultrasound, NoUS=No Ultrasound